Loading...
Found 53 Vision Loss trials
A listing of Vision Loss medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
- Sort by
- Last updated
The study evaluates the efficacy and safety of brenipatide vs. placebo as an add-on to ongoing MDD treatment. Eligible participants have MDD in remission or near remission with residual symptoms. They will complete a ~4-week Screening period before randomization, followed by a Double-Blind Adjunctive Treatment period until relapse, other discontinuation …
This is a Phase III, multi-centre, randomised, double-blind, parallel-group, event-driven study in patients with chronic HF and impaired kidney function who had a recent HF event. The aim is to evaluate the effect of balcinrenone/dapagliflozin vs dapagliflozin, given once daily on top of other classes of SoC, on CV death …
The study evaluates the efficacy and safety of Brenipatide vs. placebo as an add-on to ongoing MDD treatment. Eligible participants have MDD in remission or near remission with residual symptoms. They will complete a ~4-week Screening period before randomization, followed by a Double-Blind Adjunctive Treatment period until relapse, other discontinuation …
A5374 is a phase I/IIa randomized, two-arm, double-blind placebocontrolled, multi-step strategy trial to evaluate safety and efficacy of therapeutic vaccination with chimpanzee adenovirus (ChAdV)- and poxvirus modified vaccinia Ankara (MVA)-vectored vaccines in a sequential regimen with the Toll-like Receptor 7 (TLR7) agonist vesatolimod (VES) and two broadly neutralizing antibodies (bNAbs) …
This study will evaluate the efficacy and safety of brenipatide vs placebo as an add-on to stable standard of care (SoC) in adults with BD I/II in remission or near remission with residual symptoms. The primary measure is time to relapse. The study includes Screening (~4 weeks), Double-Blind Treatment (until …
The study is designed to evaluate the efficacy and safety of intraputaminal delivery of AAV2-GDNF gene therapy in subjects with moderate Parkinson's disease and demonstrate proof-of-concept. Subjects will be randomized to 1 of 2 treatment arms, AAV2-GDNF surgery or control surgery and will undergo screening, two baseline visits, perioperative procedures, …
A Dose-Finding, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of GSK4532990 for Steatohepatitis in Adults with Alcohol-related Liver Disease (ALD) for more information about the study please check out: https://starlightgsk.com/
This is a randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy in delaying relapse of depressive symptoms as well as the safety and tolerability of NBI-1065845 1 mg administered orally once daily (qd) as an adjunctive antidepressant in subjects 18 years of age with moderate or severe MDD, who …
This is a multicenter, randomized, quadruple-blind, sham controlled, 2-part, embedded IDE clinical trial. The main objective is to evaluate the efficacy and safety of Cardiac Contractility Modulation (CCM) therapy in patients with symptomatic HF with LVEF 40-60%. The study is divided into 3 phases, screening, randomization (where 2/3 will be …
The AG10-501 ACT-EARLY study is a randomized, multicenter, double-blind, placebo-controlled study of acoramidis for prevention of ATTR. The objective of this study is to evaluate if the use of acoramidis as a prophylactic intervention in individuals who are carriers of a known pathogenic TTR variant but with no clinical evidence …
Please choose between Voice or SMS based delivery of verification code
or